Generic placeholder image

Current Neuropharmacology

Author(s): Hiroshi Mitoma* and Mario Manto

DOI: 10.2174/1570159X1701181129111212

DownloadDownload PDF Flyer Cite As
The Era of Cerebellar Therapy

Page: [3 - 6] Pages: 4

  • * (Excluding Mailing and Handling)

Abstract

Major advances in our understanding of the neurology/pathology, anatomy/physiology, and molecular biology of the cerebellum have opened a new door for cerebellar ataxias (CAs). We have now entered in the ‘era of therapies’. Cures are knocking at the door. We discuss the hot topics in the therapeutic protocols available for CAs, including aminopyridines, noninvasive cerebellar stimulation, anti-oxidant drugs and therapies for immune-mediated cerbellar ataxias (IMCAs), topics emphasized in this issue. The history of the cerebellum is a typical example of the importance of apparently divergent and multi-disciplinary approaches.

Keywords: Cerebellar ataxias, cerebellum, therapy, aminopyridines, anti-oxidant drugs, noninvasive cerebellar stimulation, immunotherapies.

[1]
Manto, M. The cerebellum, cerebellar disorders, and cerebellar research-two centuries of discoveries. Cerebellum, 2008, 7(4), 505-516. [http://dx.doi.org/10.1007/s12311-008-0063-7]. [PMID: 18855093].
[2]
Bodranghien, F.; Bastian, A.; Casali, C.; Hallett, M.; Louis, E.D.; Manto, M.; Mariën, P.; Nowak, D.A.; Schmahmann, J.D.; Serrao, M.; Steiner, K.M.; Strupp, M.; Tilikete, C.; Timmann, D.; van Dun, K. Consensus paper: Revisiting the symptoms and signs of cerebellar syndrome. Cerebellum, 2016, 15(3), 369-391. [http://dx.doi.org/ 10.1007/s12311-015-0687-3]. [PMID: 26105056].
[3]
Babinski, J. Sur le rôle du cervelet dans les actes volitionnels nécessitant une succession rapide de mouvements (diadococinésie). Rev. Neurol. (Paris), 1902, 10, 1013-1015.
[4]
Holmes, G. The symptoms of acute cerebellar injuries due to gunshot injuries. Brain, 1917, 40, 461-535. [http://dx.doi.org/10.1093/ brain/40.4.461].
[5]
Eccles, J.C.; Ito, M.; Szentágothai, J. The cerebellum as a neuronal machine; Springer-Verlag: New York, 1967. [http://dx.doi.org/10. 1007/978-3-662-13147-3]
[6]
Llinás, R.R. Inferior olive oscillation as the temporal basis for motricity and oscillatory reset as the basis for motor error correction. Neuroscience, 2009, 162(3), 797-804. [http://dx.doi.org/10. 1016/j.neuroscience.2009.04.045]. [PMID: 19393291].
[7]
Ito, M. Cerebellar circuitry as a neuronal machine. Prog. Neurobiol., 2006, 78(3-5), 272-303. [http://dx.doi.org/10.1016/j.pneurobio. 2006.02.006]. [PMID: 16759785].
[8]
Timmann, D.; Daum, I. Cerebellar contributions to cognitive functions: a progress report after two decades of research. Cerebellum, 2007, 6(3), 159-162. [http://dx.doi.org/10.1080/14734220701496448]. [PMID: 17786810].
[9]
Koziol, L.F.; Budding, D.; Andreasen, N.; D’Arrigo, S.; Bulgheroni, S.; Imamizu, H.; Ito, M.; Manto, M.; Marvel, C.; Parker, K.; Pezzulo, G.; Ramnani, N.; Riva, D.; Schmahmann, J.; Vandervert, L.; Yamazaki, T. Consensus paper: the cerebellum’s role in movement and cognition. Cerebellum, 2014, 13(1), 151-177. [http://dx.doi.org/10.1007/s12311-013-0511-x]. [PMID: 23996631].
[10]
Mariën, P.; Ackermann, H.; Adamaszek, M.; Barwood, C.H.; Beaton, A.; Desmond, J.; De Witte, E.; Fawcett, A.J.; Hertrich, I.; Küper, M.; Leggio, M.; Marvel, C.; Molinari, M.; Murdoch, B.E.; Nicolson, R.I.; Schmahmann, J.D.; Stoodley, C.J.; Thürling, M.; Timmann, D.; Wouters, E.; Ziegler, W. Consensus paper: Language and the cerebellum: an ongoing enigma. Cerebellum, 2014, 13(3), 386-410. [PMID: 24318484].
[11]
Manto, M.; Mariën, P. Schmahmann’s syndrome - identification of the third cornerstone of clinical ataxiology. Cerebellum Ataxias, 2015, 2, 2. [http://dx.doi.org/10.1186/s40673-015-0023-1]. [PMID: 26331045].
[12]
Hoche, F.; Guell, X.; Vangel, M.G.; Sherman, J.C.; Schmahmann, J.D. The cerebellar cognitive affective/Schmahmann syndrome scale. Brain, 2018, 141(1), 248-270. [http://dx.doi.org/10.1093/ brain/awx317]. [PMID: 29206893].
[13]
Bostan, A.C.; Strick, P.L. The basal ganglia and the cerebellum: nodes in an integrated network. Nat. Rev. Neurosci., 2018, 19(6), 338-350. [http://dx.doi.org/10.1038/s41583-018-0002-7]. [PMID: 29643480].
[14]
Ilg, W.; Bastian, A.J.; Boesch, S.; Burciu, R.G.; Celnik, P.; Claaßen, J.; Feil, K.; Kalla, R.; Miyai, I.; Nachbauer, W.; Schöls, L.; Strupp, M.; Synofzik, M.; Teufel, J.; Timmann, D. Consensus paper: management of degenerative cerebellar disorders. Cerebellum, 2014, 13(2), 248-268. [http://dx.doi.org/10.1007/s12311-013-0531-6]. [PMID: 24222635].
[15]
Cendelin, J. Transplantation and stem cell therapy for cerebellar degenerations. Cerebellum, 2016, 15(1), 48-50. [http://dx.doi.org/ 10.1007/s12311-015-0697-1]. [PMID: 26155762].
[16]
Strupp, M.; Kalla, R.; Claassen, J.; Adrion, C.; Mansmann, U.; Klopstock, T.; Freilinger, T.; Neugebauer, H.; Spiegel, R.; Dichgans, M.; Lehmann-Horn, F.; Jurkat-Rott, K.; Brandt, T.; Jen, J.C.; Jahn, K. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology, 2011, 77(3), 269-275. [http://dx.doi.org/10.1212/WNL.0b013e318225ab07]. [PMID: 21734179].
[17]
Kalla, R.; Glasauer, S.; Büttner, U.; Brandt, T.; Strupp, M. 4-aminopyridine restores vertical and horizontal neural integrator function in downbeat nystagmus. Brain, 2007, 130(Pt 9), 2441-2451. [http://dx.doi.org/10.1093/brain/awm172]. [PMID: 17664175].
[18]
Alviña, K.; Khodakhah, K. The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia. J. Neurosci., 2010, 30(21), 7258-7268. [http://dx.doi.org/10.1523/JNEUROSCI.3582-09.2010]. [PMID: 20505092].
[19]
Benussi, A.; Koch, G.; Cotelli, M.; Padovani, A.; Borroni, B. Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. Mov. Disord., 2015, 30(12), 1701-1705. [http://dx.doi.org/10.1002/mds.26356]. [PMID: 26274840].
[20]
Mitoma, H.; Manto, M. The physiological basis of therapies for cerebellar ataxias. Ther. Adv. Neurol. Disorder., 2016, 9(5), 396-413. [http://dx.doi.org/10.1177/1756285616648940]. [PMID: 27582895].
[21]
Panyakaew, P.; Cho, H.J.; Srivanitchapoom, P.; Popa, T.; Wu, T.; Hallett, M. Cerebellar brain inhibition in the target and surround muscles during voluntary tonic activation. Eur. J. Neurosci., 2016, 43(8), 1075-1081. [http://dx.doi.org/10.1111/ejn.13211]. [PMID: 26900871].
[22]
Wong, A.; Yang, J.; Cavadini, P.; Gellera, C.; Lonnerdal, B.; Taroni, F.; Cortopassi, G. The Friedreich’s ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet., 1999, 8(3), 425-430. [http://dx.doi.org/10.1093/hmg/8.3.425]. [PMID: 9949201].
[23]
Mitoma, H.; Adhikari, K.; Aeschlimann, D.; Chattopadhyay, P.; Hadjivassiliou, M.; Hampe, C.S.; Honnorat, J.; Joubert, B.; Kakei, S.; Lee, J.; Manto, M.; Matsunaga, A.; Mizusawa, H.; Nanri, K.; Shanmugarajah, P.; Yoneda, M.; Yuki, N. Consensus paper: neuroimmune mechanisms of cerebellar ataxias. Cerebellum, 2016, 15(2), 213-232. [http://dx.doi.org/10.1007/s12311-015-0664-x]. [PMID: 25823827].
[24]
Neureither, F.; Ziegler, K.; Pitzer, C.; Frings, S.; Möhrlen, F. Impaired motor coordination and learning in mice lacking anoctamin 2 calcium-gated chloride channels. Cerebellum, 2017, 16(5-6), 929-937. [http://dx.doi.org/10.1007/s12311-017-0867-4]. [PMID: 28536821].
[25]
Grothe, M.; Lotze, M.; Langner, S.; Dressel, A. Impairments in walking ability, dexterity, and cognitive function in multiple sclerosis are associated with different regional cerebellar gray matter loss. Cerebellum, 2017, 16(5-6), 945-950. [http://dx.doi.org/10. 1007/s12311-017-0871-8]. [PMID: 28612183].
[26]
He, N.; Langley, J.; Huddleston, D.E.; Ling, H.; Xu, H.; Liu, C.; Yan, F.; Hu, X.P. Improved neuroimaging atlas of the dentate nucleus. Cerebellum, 2017, 16(5-6), 951-956. [http://dx.doi.org/10. 1007/s12311-017-0872-7]. [PMID: 28669058].